Role of Sphingosine Kinase 1 in the Pathogenesis of Idiopathic Pulmonary Fibrosis: Identification of Novel Transcription Factors as Potential Therapeutic Targets by in silico Analysis

被引：0
|
作者：
Krishnan, Yashaswin
Sudhadevi, Tara
Ramachandran, Ramaswamy
Natarajan, Viswanathan
机构：
来源：
PHYSIOLOGY | 2023年 / 38卷
关键词：
D O I：
10.1152/physiol.2023.38.S1.5715018
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potential
    Koerbelin, Jakob
    Klein, Julius
    Matuszcak, Christiane
    Runge, Johannes
    Harbaum, Lars
    Klose, Hans
    Hennigs, Jan K.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [22] Myriad Functions of Stanniocalcin-1 (STC1) Cover Multiple Therapeutic Targets in the Complicated Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)
    Ohkouchi, Shinya
    Ono, Manabu
    Kobayashi, Makoto
    Hirano, Taizou
    Tojo, Yutaka
    Hisata, Shu
    Ichinose, Masakazu
    Irokawa, Toshiya
    Ogawa, Hiromasa
    Kurosawa, Hajime
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2015, 9 : 91 - 96
  • [23] Identification of potential biomarkers for idiopathic pulmonary fibrosis and validation of TDO2 as a potential therapeutic target
    Wang, Ru
    Yang, Yan-Mei
    WORLD JOURNAL OF CARDIOLOGY, 2023, 15 (06): : 293 - 308
  • [24] CKD-MBD: from the Pathogenesis to the Identification and Development of Potential Novel Therapeutic Targets
    Elias, Rosilene Motta
    Dalboni, Maria Aparecida
    Coelho, Ana Carolina E.
    Moyses, Rosa M. A.
    CURRENT OSTEOPOROSIS REPORTS, 2018, 16 (06) : 693 - 702
  • [25] CKD-MBD: from the Pathogenesis to the Identification and Development of Potential Novel Therapeutic Targets
    Rosilene Motta Elias
    Maria Aparecida Dalboni
    Ana Carolina E. Coelho
    Rosa M. A. Moysés
    Current Osteoporosis Reports, 2018, 16 : 693 - 702
  • [26] Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis
    Sklepkiewicz, Piotr
    Dymek, Barbara A.
    Mlacki, Michal
    Koralewski, Robert
    Mazur, Marzena
    Nejman-Gryz, Patrycja
    Korur, Serdar
    Zagozdzon, Agnieszka
    Rymaszewska, Aleksandra
    von der Thusen, Jan H.
    Siwinska, Anna M.
    Guner, Nazan Cemre
    Cheda, Lukasz
    Paplinska-Goryca, Magdalena
    Proboszcz, Malgorzata
    van den Bosch, Thierry P. P.
    Gorska, Katarzyna
    Golab, Jakub
    Kaminski, Rafal M.
    Krenke, Rafal
    Golebiowski, Adam
    Dzwonek, Karolina
    Dobrzanski, Pawel
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 919
  • [27] Genetic insights into idiopathic pulmonary fibrosis: a multi-omics approach to identify potential therapeutic targets
    Wen, Zhuofeng
    Liang, Weixuan
    Yang, Ziyang
    Liu, Junjie
    Yang, Jing
    Xu, Runge
    Lin, Keye
    Pan, Jia
    Chen, Zisheng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [28] The Role of Proteinase-activated Receptor-2 in Idiopathic Pulmonary Fibrosis: Is There Really Novel Therapeutic Potential Here?
    Matej, R.
    Olejar, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (04) : 458 - 459
  • [29] The Role Of Hmgb1 And Mip3a In The Pathogenesis Of Idiopathic Pulmonary Fibrosis
    Zhao, Y. D.
    Lin, K.
    Granton, E.
    Yu, A.
    Yun, H. Z. H.
    Wu, M. O.
    Wu, L.
    Granton, J.
    De Perrot, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [30] MMP-1 and ADAM10 as Targets for Therapeutic Intervention in Idiopathic Pulmonary Fibrosis
    Peng, Zhihong
    Konai, Mohini Mohan
    Avila-Cobian, Luis F.
    Wang, Man
    Mobashery, Shahriar
    Chang, Mayland
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 5 (08) : 548 - 554
12345